academic article

• Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. 2017
• PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS..  Journal of medical genetics.  53:800-811. 2016